Почетна › Рак на дојка › Калифорнија › San Diego
Клинички испитувања за Рак на дојка во San Diego, CA
Една студија за Рак на дојка бара учесници на локација во или блиску до San Diego. Отворете ја за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Се регрутираФаза 3
- University of California San Diego Moores Cancer Center, San Diego
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Се регрутираФаза 1/2
- University of San Diego Moores Cancer Center, La Jolla · на 11 милји
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Се регрутираФаза 3
- Sharp Rees Stealy Medical Group Inc, San Diego
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Се регрутираФаза 1
- University of California San Diego Moores Cancer Center, San Diego
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Се регрутираФаза 1/2
- Sharp Memorial Hospital, San Diego
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Се регрутираФаза 2
- California Protons Cancer Therapy Center, San Diego
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
Се регрутираФаза 3
- California Protons Cancer Therapy Center, San Diego
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Се регрутираФаза 2
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Се регрутираФаза 3
- Clinical Trial Site, La Jolla · на 11 милји
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Се регрутираФаза 3
- Moores Cancer Center, La Jolla · на 11 милји
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
Се регрутираДобредојдени се здрави волонтери
- University of California San Diego, San Diego
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Се регрутираФаза 3
- University Of California - San Diego Moores Cancer Center, La Jolla · на 11 милји
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Се регрутираФаза 3
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Се регрутираФаза 1/2
- University of California San Diego (UCSD) - Koman Family Outpatient Pavilion ? La Jolla, La Jolla · на 11 милји
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Се регрутираФаза 1
- Scripps Health, San Diego
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Се регрутираФаза 1
- UCSD Moores Cancer Center, La Jolla · на 11 милји
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Се регрутираФаза 1/2
- University of California San Diego Medical Center, San Diego
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Се регрутираФаза 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · на 11 милји
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Се регрутираФаза 1/2
- University of California-San Diego, La Jolla · на 11 милји
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Се регрутираФаза 3
- Scripps Health, La Jolla · на 11 милји
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Се регрутираФаза 3
- UC San Diego, San Diego
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Се регрутираФаза 1
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Се регрутираНабљудувачка студија
- University of California, San Diego, San Diego
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Се регрутираФаза 3
- Kaiser Permanente-Rio San Diego, San Diego
- Kaiser Permanente-San Diego Zion, San Diego
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
Се регрутираДобредојдени се здрави волонтери
- University of California, San Diego, La Jolla · на 11 милји
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Се регрутираФаза 1
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Се регрутираФаза 2
- Scripps Health, San Diego
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Се регрутираФаза 3
- UC San Diego Medical Center - Hillcrest, San Diego
- California Protons Cancer Therapy Center, San Diego
- UC San Diego Moores Cancer Center, La Jolla · на 11 милји
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
Се регрутираФаза 1
- University of California, San Diego, La Jolla · на 11 милји
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Се регрутираФаза 3
- University of California San Diego - Moores Cancer Center, La Jolla · на 11 милји
E-Mindfulness Approaches for Living After Breast Cancer
Се регрутираФаза 3
- Kaiser Permanente-San Diego Zion, San Diego
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Се регрутираФаза 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- Investigative Site #101, La Jolla · на 11 милји
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Се регрутираФаза 2
- University of California San Diego, La Jolla · на 11 милји
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Се регрутираФаза 1/2
- SHARP Healthcare, San Diego
Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.
Се регрутираФаза 2
- University of California, San Diego, La Jolla · на 11 милји
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
Се регрутираФаза 1/2
- Research Site, La Jolla · на 11 милји
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Се регрутира
- UC San Diego Health, La Jolla · на 11 милји
Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance
Се регрутира
- University of California, San Diego, La Jolla · на 11 милји
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Се регрутираНабљудувачка студија
- Massive Bio SYNERGY-AI site, La Jolla · на 11 милји
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Се регрутираФаза 1
- University of California-San Diego, San Diego
Испитувања за Рак на дојка во други градови
- New York City, NY136 студии
- Houston, TX126 студии
- Boston, MA112 студии
- Nashville, TN81 студија
- Los Angeles, CA73 студии
- Edison, NJ68 студии
- St. Louis, MO64 студии
- Queens, NY64 студии
- Durham, NC64 студии
- Chicago, IL59 студии
- Philadelphia, PA56 студии
- Dallas, TX55 студии
Други студии во San Diego
- Рак на бели дробови со не-мали клетки48 студии
- Рак (сите типови)32 студии
- Рак на простата31 студија
- Метастатски карцином30 студии
- Колоректален карцином25 студии
- Карцином на јајниците24 студии
- Карцином на панкреасот24 студии
- Рак на бели дробови23 студии
- Дебелина23 студии
- Срцева слабост23 студии
- Депресија21 студија
- Меланом18 студии
Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.